We are still some way off reaching human-level artificial intelligence despite rapid advances in the technology, an early investor in DeepMind told CNBC.
Shopify offloads logistics business to Flexport
The sale marks a reversal for Shopify, which had spent years building out its own logistics and order fulfillment operations.
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, its only marketable product.
Peloton shares plunge after company reports wider-than-expected loss
Peloton reported subscription growth despite its ninth straight quarter of losses.
Stocks making the biggest moves before the bell: Paramount, PacWest, Shopify & more
These are the stocks posting the largest moves in premarket trading.
Don’t expect an IPO market revival in these conditions even as J&J’s Kenvue breaks drought
Kenvue, Johnson & Johnson’s spinoff, will debut on Thursday. But the current environment is far from hospitable for IPOs.
Making these 5 moves can help you save big on the massive cost of college
The high cost of college is a financial stress for many families, but there are steps you can take now to reduce the cost.
Macy’s opens more strip mall stores as expansion strategy faces pivotal test
Macy’s push into smaller and off-mall stores is its answer to investors who see department stores as dull and irrelevant.
This building materials stock has pricing power and can jump 40%, Goldman Sachs says
The firm upgraded this concrete maker to buy after the firm’s strong first-quarter results.
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
Novo Nordisk said Thursday that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand.